MedTrace Logo

Pilot Study on the Efficacy of Pascoflair in an Acute Stressful Situation (TSST)

NCT01665170 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2015-12-09

Study results available
· View outcomes & findings →

Summary

A randomized, double blind, placebo-controlled pilot study on the efficacy of Passiflora incarnata L. in an acute stressful situation

Conditions

  • Healthy
  • Stress

Interventions

DRUG

Passiflora incarnata

3 x 1 tablet per day for 3 days

DRUG

Placebo

3 x 1 ablet per day for 3 days

Sponsors & Collaborators

  • Daacro

    collaborator NETWORK

  • Pascoe Pharmazeutische Praeparate GmbH

    lead INDUSTRY

Principal Investigators

  • Michael Clemens, MD, Prof · Klinikum Mutterhaus der Borromäerinnen GmbH, Feldstr. 16, 54290 Trier

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
25 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-05-31
Primary Completion
2012-08-31
Completion
2012-08-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01665170 on ClinicalTrials.gov